Clinical Trial Update: A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigating ITCA 650 for type 2 diabetes was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• ITCA 650

Snippet

Sponsor: Intarcia Therapeutics | Conditions: Type 2 Diabetes | Phase 3 | Status: TERMINATED